KRAS and pancreatic neoplasm: Pancreatic cancer mouse models have been established using a variety of methods, including a transgenic mouse model with the most representative tumor suppressor gene in PDAC, Kras, being mutated or chemically induced in pancreatic cancer [39] and a xenograft mouse model consisting of heterotopic or orthotopic xenografts [40].